You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Autologous Stem Cell Transplant

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial (Iberdomide, Daratumumab/rHuPH20 Co-formulation)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Oct 25, 2023

Based on Maintenance Therapy Post Autologous Stem Cell

Recruiting
  • Multiple Myeloma
  • Autologous Stem Cell Transplant
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Jul 27, 2022

Morbidity, Long-term Side Effects and Quality of Life in

Recruiting
  • Germ Cell Tumor
    • Villejuif, France
      Gustave Roussy
    Jun 2, 2023

    Multiple Myeloma Trial in Salt Lake City (Budesonide EC, Placebo)

    Not yet recruiting
    • Multiple Myeloma
    • Budesonide EC
    • Placebo
    • Salt Lake City, Utah
      Huntsman Cancer Institute at the University of Utah
    Jan 9, 2023

    T Cell Lymphoma Trial in Kansas City (Brentuximab Vedotin)

    Withdrawn
    • T Cell Lymphoma
    • Brentuximab Vedotin
    • Kansas City, Kansas
      The University of Kansas Cancer Center, Westwood Campus
    Feb 1, 2023

    T-Cell Lymphoma Trial in Saint Louis (Duvelisib, Peripheral blood draw)

    Recruiting
    • T-Cell Lymphoma
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jul 18, 2022

    Autologous Stem Cell Transplant Trial in Edmonton (Airvo)

    Not yet recruiting
    • Autologous Stem Cell Transplant
    • Airvo
    • Edmonton, Alberta, Canada
      Cross Cancer Institute
    Apr 28, 2022

    Non-Hodgkin Lymphoma, Hodgkin Lymphoma Trial in Minneapolis (drug, procedure, biological, radiation)

    Recruiting
    • Non-Hodgkin Lymphoma
    • Hodgkin Lymphoma
    • Minneapolis, Minnesota
      Masonic Cancer Center, University of Minnesota
    Jan 25, 2023

    Systemic Lupus Erythematosus, Systemic Sclerosis Trial in Philadelphia (Depletion of CD3/CD19 in an autologous stem cell

    Recruiting
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Depletion of CD3/CD19 in an autologous stem cell transplant
    • Philadelphia, Pennsylvania
      Children's Hospital of Philadelphia
    May 23, 2022

    Multiple Myeloma Trial in New York (Tremelimumab, Durvalumab, Prevnar-13)

    Terminated
    Has Results
    • Multiple Myeloma
    • New York, New York
    • +1 more
    Oct 3, 2022

    Myeloma Trial in Philadelphia (Belantamab mafodotin)

    Recruiting
    • Myeloma
    • Belantamab mafodotin
    • Philadelphia, Pennsylvania
      Abramson Cancer Center at University of Pennsylvania
    Jun 13, 2022

    Plasma Cell Leukemia, Plasmacytoma, Recurrent Plasma Cell Myeloma Trial in Houston (procedure, drug, other)

    Active, not recruiting
    • Plasma Cell Leukemia
    • +3 more
    • Autologous Hematopoietic Stem Cell Transplantation
    • +7 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 6, 2022

    Multiple Myeloma Trial (GPC-100, Propranolol, G-CSF)

    Not yet recruiting
    • Multiple Myeloma
    • (no location specified)
    Sep 29, 2022

    Multiple Myeloma, Lymphoma, Transplant-Related Disorder Trial in Los Angeles (Feedback)

    Recruiting
    • Multiple Myeloma
    • +2 more
    • Feedback
    • Los Angeles, California
      Cedars-Sinai Medical Center
    Feb 24, 2022

    Multiple Myeloma Trial in Birmingham (Multi-modal Exercise Regimen, Dietary Guidelines)

    Not yet recruiting
    • Multiple Myeloma
    • Multi-modal Exercise Regimen
    • Dietary Guidelines
    • Birmingham, Alabama
      Kirklin Clinic of UAB Hospital
    Nov 29, 2022

    Non-Hodgkin's Lymphoma, Plasma Cell Myeloma Trial in Philadelphia (procedure, drug, other)

    Completed
    • Non-Hodgkin's Lymphoma
    • Plasma Cell Myeloma
    • Hematopoietic Cell Transplantation
    • +2 more
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Nov 16, 2022

    Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Transformed B-Cell Lymphoma Trial in Saint Louis (Mosunetuzumab,

    Not yet recruiting
    • Diffuse Large B Cell Lymphoma
    • +3 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jul 14, 2022

    AL Amyloidosis Trial (procedure, drug, other)

    Not yet recruiting
    • AL Amyloidosis
    • Autologous Hematopoietic Stem Cell Transplantation
    • +15 more
    • (no location specified)
    Aug 28, 2023

    Plasma Cell Leukemia, Plasma Cell Myeloma Trial in Houston (procedure, biological, other, drug)

    Active, not recruiting
    • Plasma Cell Leukemia
    • Plasma Cell Myeloma
    • Autologous Hematopoietic Stem Cell Transplantation
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 18, 2022

    Plasma Cell Myeloma Trial in Jacksonville (procedure, biological, drug)

    Active, not recruiting
    • Plasma Cell Myeloma
    • Autologous Hematopoietic Stem Cell Transplantation
    • +2 more
    • Jacksonville, Florida
      Mayo Clinic in Florida
    Mar 25, 2022

    Autologous Transplant, Myeloma Trial in Cleveland (Mycobiome Supporting Diet)

    Not yet recruiting
    • Autologous Transplant
    • Myeloma
    • Mycobiome Supporting Diet
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center, Case Comprehensiv
    Jul 22, 2022

    Multiple Myeloma, Stem Cell Transplant Complications Trial in Boston (PARE, Waitlist Control Group)

    Not yet recruiting
    • Multiple Myeloma
    • Stem Cell Transplant Complications
    • PARE
    • Waitlist Control Group
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Jan 30, 2023

    Diffuse Large B Cell Lymphoma Trial in Saint Louis (Blinatumomab, Autologous stem cell transplant, Carmustine)

    Active, not recruiting
    • Diffuse Large B Cell Lymphoma
    • Saint Louis, Missouri
      Washington University School of Medicine
    May 4, 2022

    Oral Mucositis in Patient's Undergoing Melphalan Conditioning

    Withdrawn
    • Mucositis
    • +3 more
    • Melphalan kinetic study
    • +2 more
    • Indianapolis, Indiana
    • +1 more
    Jan 6, 2022

    Recurrent DLBCL, Recurrent DLBCL, Not Otherwise Specified, Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6

    Withdrawn
    • Recurrent Diffuse Large B-Cell Lymphoma
    • +9 more
    • Autologous Hematopoietic Stem Cell Transplantation
    • +5 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 11, 2023